Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10849885
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
granted -
US 10849911
Low dose compositions of Aramachol salts
granted -
US 10849912
Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment
granted -
US 10851072
Inhibitors of Rho/MRTF/SRF-mediated gene transcription and methods for use of the same
granted -
US 10851110
Heterocyclic inhibitors of PTPN11
granted -
US 10851377
Methods and compositions for treating a proprotein convertase subtilisin kexin (PCSK9) gene-associated disorder
granted -
US 10849935
Method to suppress the systemic toxicity of chemotherapeutic drugs
granted -
US 10849988
Hydrogel for engineered immune response to D-chirality peptides
granted -
US 10851158
Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof
granted -
US 10852220
Methods and devices for high throughput purification
granted -
US 10851463
Membrane template synthesis of microtube engines
granted -
US 10851367
Tissue-specific genome engineering using CRISPR-Cas9
granted -
US 10851412
Cell potency assay for therapeutic potential
granted -
US 10851358
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
granted -
US 10851173
Anti-OX40 antibodies and methods of using the same
granted -
US 10851115
Heterocyclic compounds as RSV inhibitors
granted -
US 10851112
Anti-HCMV virus compound
granted -
US 10851146
Method for preparing liraglutide intermediate polypeptide
granted -
US 10851101
Compounds for treating spinal muscular atrophy
granted -
US 10851102
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
granted -
US 10851093
Tyrosine kinase inhibitors
granted -
US 10851088
Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
granted -
US 10851104
Valbenazine salts and polymorphs thereof
granted -
US 10851103
Valbenazine salts and polymorphs thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.